In today’s digital age, misinformation spreads faster than ever, often driven by sensational headlines and influencer content ...

There’s a growing trend of LMS platforms leveraging AI to offer smart suggestions, automated assessments and adaptive ...

Biogen and Eisai’s Alzheimer’s disease (AD) drug Leqembi (lecanemab) has shown continued benefit over four years, according ...

Novo Nordisk’s Alhemo (concizumab-mtci) has been approved by the US Food and Drug Administration (FDA) to prevent or reduce ...

Yet this simple difference translated into a median progression-free survival (PFS) of 11.3 months versus 5.7 months for ...